Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1780616
PUBLISHER: GlobalData | PRODUCT CODE: 1780616
United States Knee Reconstruction Market Outlook to 2033 - Primary Knee Replacement, Partial Knee Replacement and Revision Knee Replacement
PUBLISHED:
PAGES: 59 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "United States Knee Reconstruction Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Knee Reconstruction market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Primary Knee Replacement, Partial Knee Replacement and Revision Knee Replacement
The United States Knee Reconstruction Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Knee Reconstruction Market.
- Global corporate-level profiles of key companies operating within the United States Knee Reconstruction Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Knee Reconstruction is segmented as follows -
- Primary Knee Replacement
- Partial Knee Replacement
- Revision Knee Replacement
Reasons to Buy
The United States Knee Reconstruction Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME25765CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Knee Reconstruction Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Knee Reconstruction Market, United States
- 3.1 Knee Reconstruction Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Partial Knee Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Knee Reconstruction Market, United States, Volume (Units), 2018-2033
- 3.2.1 Partial Knee Replacement Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Knee Reconstruction Market, United States, Average Price ($) , 2018-2033
- 3.4 Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Knee Reconstruction Market
- 4.1 Zimmer Biomet Holdings Inc
- 4.1.1 Company Overview
- 4.2 Stryker Corp
- 4.2.1 Company Overview
- 4.3 DePuy Synthes Inc
- 4.3.1 Company Overview
- 4.4 Smith & Nephew Plc
- 4.4.1 Company Overview
- 4.5 Waldemar Link GmbH & Co KG
- 4.5.1 Company Overview
- 4.6 Medacta International SA
- 4.6.1 Company Overview
- 4.7 MicroPort Scientific Corp
- 4.7.1 Company Overview
- 4.8 Enovis Corp
- 4.8.1 Company Overview
- 4.9 Corin Group Ltd
- 4.9.1 Company Overview
- 4.10 Amplitude SAS
- 4.10.1 Company Overview
- 4.11 B. Braun Melsungen AG
- 4.11.1 Company Overview
- 4.12 United Orthopedic Corp
- 4.12.1 Company Overview
- 4.13 Exactech Inc
- 4.13.1 Company Overview
- 4.14 Corentec Co Ltd
- 4.14.1 Company Overview
- 4.15 Baumer SA
- 4.15.1 Company Overview
5 Knee Reconstruction Market Pipeline Products
6 Financial Deals Landscape
- 6.1 Debt Offerings
- 6.1.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 May 20, 2025: FDA clears Trax Surgical's compression staple system for orthopaedic use
- 7.1.2 Jan 15, 2025: The University of Florida Appoints Waste Pro Vice President to Advisory Board
- 7.1.3 Dec 11, 2024: Paragon 28 Appoints Dave Demski to Board of Directors
- 7.1.4 Aug 08, 2024: Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance
- 7.2 Financial Announcements
- 7.2.1 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel
- 7.2.2 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
- 7.2.3 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
- 7.2.4 Jan 13, 2025: Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
- 7.2.5 Nov 12, 2024: Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance
- 7.2.6 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
- 7.2.7 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
- 7.2.8 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
- 7.2.9 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
- 7.2.10 Aug 08, 2024: Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance
- 7.2.11 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
- 7.2.12 Jul 09, 2024: Orthofix to Report Second Quarter 2024 Financial Results
- 7.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
- 7.3 Government and Public Interest
- 7.3.1 Mar 25, 2025: Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference
- 7.3.2 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
- 7.3.3 Feb 10, 2025: Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
- 7.3.4 Nov 18, 2024: Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference
- 7.3.5 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
- 7.3.6 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
- 7.4 Legal And Regulatory
- 7.4.1 Jun 13, 2025: FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer, Backed by Dana-Farber Research
- 7.4.2 Jun 04, 2025: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
- 7.5 Other Significant Developments
- 7.5.1 Oct 04, 2024: Rapides Regional performs first wireless, handheld robotic knee replacement surgery in Louisiana
- 7.5.2 Jul 23, 2024: ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
- 7.6 Product News
- 7.6.1 Jun 10, 2025: New Study Shows Outstanding Long-Term Outcomes for Zimmer Total Ankle Replacement Using Unique Lateral Approach
- 7.6.2 Dec 12, 2024: Researchers at Medical College of Wisconsin Advance Treatments for Hip, Knee Replacements
- 7.6.3 Nov 22, 2024: Geisinger, Medacta Announce First Shoulder Replacement with Lifetime Guarantee
- 7.6.4 Nov 17, 2024: Surprising Study Finds No Link Between Rheumatoid Arthritis and Transfusion Risk After Knee Replacement
- 7.7 Strategy And Business Planning
- 7.7.1 Jan 08, 2025: Moonlake Initiates Three New Clinical Trials and Further Expands the Portfolio of Indications for the Nanobody Sonelokimab
8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
Product Code: GDME25765CCDB
List of Table
List of Tables
- Table 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Knee Reconstruction Market, United States, Volume (Units), 2018-2033
- Table 5: Partial Knee Replacement Market, United States, Volume (Units), 2018-2033
- Table 6: Primary Knee Replacement Market, United States, Volume (Units), 2018-2033
- Table 7: Knee Reconstruction Market, United States, Average Price ($), 2018-2033
- Table 8: Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2024
- Table 9: Knee Reconstruction Market Pipeline Products
- Table 10: Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
- Table 11: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figure
List of Figures
- Figure 1: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Knee Reconstruction Market, United States, Volume (Units), 2018-2033
- Figure 5: Partial Knee Replacement Market, United States, Volume (Units), 2018-2033
- Figure 6: Primary Knee Replacement Market, United States, Volume (Units), 2018-2033
- Figure 7: Knee Reconstruction Market, United States, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.